2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




BTG Acquires Galil Medical

May 6, 2016 -- BTG plc announced that it has entered into an agreement to acquire Galil Medical Inc., which owns, manufactures, and sells a portfolio of cryoablation systems a…

SIR Issues Guidelines on Staffing for Interventional Radiology Suites

May 5, 2016 -- The Society of Interventional Radiology (SIR) has published a position statement on staffing guidelines for the interventional radiology (IR) sui…

Twelve-Month TOBA-BTK Results Presented for Intact Vascular’s Tack System

May 4, 2016 -- Intact Vascular, Inc. announced that positive 12-month results from its Tack Optimized Balloon Angioplasty -- Below-the-Knee (TOBA-BTK) clinical study were pres…

Feasibility Study Supports Boston Scientific’s JetStream XC to Treat In-Stent Restenosis

May 3, 2016 -- Results from the JETSTREAM-ISR feasibility study were published by Nicolas W. Shammas, MD, et al, in the Journal of Endovascular Therapy (JEVT; 2016;2…

Essential Medical’s Manta Large-Bore Vascular Closure Submitted for European Approval

May 2, 2016 -- Essential Medical, Inc. announced that it has submitted an application for European CE Mark approval for Manta, the company’s large-bore vascular closure …

Cook Medical Issues Global Voluntary Recall for All Beacon Tip Catheters

May 2, 2016 -- Cook Medical has initiated a global voluntary recall of all catheters made with its Beacon Tip technology, representing approximately 4.1 million units. The …

Study of Medicare Patients Finds Comparable Outcomes for CAS and CEA

April 29, 2016 -- A study of the effectiveness of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) among Medicare beneficiaries concluded that the outcomes af…

Click here for more News coverage

Current Supplement


The Fight Is On

Cases in Advanced Embolization Techniques

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $37.97  -1.38%
AstraZeneca PLC $27.96  -0.50%
Avinger $12.40  -5.85%
Boston Scientific Corporation $22.03  1.06%
BTG plc $579.00  -0.60%
Cardinal Health $76.85  -2.16%
Cardiovascular Systems Inc. $14.64  -3.37%
CR Bard Inc. $216.40  0.40%
Edwards Lifesciences Corp. $105.74  1.31%
Endologix Inc. $11.30  0.80%
Vascular Market Price  Change
Hansen Medical, Inc. $4.01  0.25%
Johnson and Johnson $112.74  -0.12%
Lombard Medical, Inc. $1.65  0.61%
Medtronic, Inc. $79.74  0.30%
Merit Medical Systems, Inc. $19.51  -1.81%
St. Jude Medical Inc. $75.10  -0.54%
Stryker $111.21  0.99%
The Medicines Company $36.20  3.46%
The Spectranetics Corporation $17.95  -1.32%
Vascular Solutions Inc. $35.56  0.17%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.